February 8, 2023
You are here:  Home  >  Health Care & Life Science  >  Current Article

Diabetes drug may be game changer


A shelved Amgen drug that could drastically reduce or eliminate insulin injections that diabetes patients take is getting new life at a Camarillo biotechnology startup. In 2013, REMD Biotherapeutics resurrected an Amgen drug designed to treat Type 2 diabetes. Now, after more than 13 years of development, the drug known as REMD-477 is starting clinical…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.